The Effects of Moringa oleifera on Blood IL-6 Levels: A Scoping Review
DOI:
https://doi.org/10.58812/jmws.v5i08.3705Kata Kunci:
Moringa Oleifera, Blood IL-6, Anti-Inflammatory, Scoping Review, Animal ModelAbstrak
Interleukin-6 (IL-6) is widely used as an inflammatory biomarker and has also become a therapeutic target in several inflammatory and malignant diseases. Moringa oleifera (MO) has been reported to possess anti-inflammatory activity, yet evidence regarding its effect on blood IL-6 levels remains limited. This scoping review analyzed available evidence on the effect of MO on blood IL-6 levels. The review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). A PubMed search was conducted using the keywords ((Moringa oleifera) AND (Interleukin-6 OR IL-6)) AND (blood), covering publications from January 2006 to January 2026. Nine studies met the inclusion criteria. All studies used animal experimental models, measured IL-6 in serum using ELISA, and applied randomized placebo-controlled designs. Most studies reported a significant reduction in blood IL-6 levels after MO intervention. The preparations included aqueous extracts, ethanol extracts, polyphenol extracts, n-butanol fractions, seed powder, and beta-sitosterol isolated from n-butanol seed extract. Overall, MO may have prophylactic potential for chronic inflammatory conditions characterized by elevated blood IL-6 levels; however, standardized preparations and human studies are still needed.
Referensi
Al-malki, A. L., & El Rabey, H. A. (2015). The antidiabetic effect of low doses of Moringa oleifera Lam. seeds on streptozotocin induced diabetes and diabetic nephropathy in male rats. BioMed Research International, 2015, 381040. https://doi.org/10.1155/2015/381040
Azevedo, I. M., Araujo-Filho, I., Teixeira, M. M. A., Moreira, M. D. F. C., & Medeiros, A. C. (2018). Wound healing of diabetic rats treated with Moringa oleifera extract. Acta Cirurgica Brasileira, 33(9), 799-805. https://doi.org/10.1590/s0102-865020180090000008
Azlan, U. K., Mediani, A., Rohani, E. R., Tong, X., Han, R., Misnan, N. M., Jam, F. A., Bunawan, H., Sarian, M. N., & Hamezah, H. S. (2022). A comprehensive review with updated future perspectives on the ethnomedicinal and pharmacological aspects of Moringa oleifera. Molecules, 27(18), 5765. https://doi.org/10.3390/molecules27185765
Bilia, A. R., Mukherjee, P. K., Andrade-Cetto, A., Katiyar, C. K., Bachar, S. C., Matsabisa, M. G., & Mandal, S. C. (2022). Editorial: Drug development of herbal medicines: Regulatory perspectives. Frontiers in Pharmacology, 13, 989934. https://doi.org/10.3389/fphar.2022.989934
Chen, L., Deng, H., Cui, H., Fang, J., Zuo, Z., Deng, J., Li, Y., Wang, X., & Zhao, L. (2018). Inflammatory responses and inflammation-associated diseases in organs. Oncotarget, 9(6), 7204-7218. https://doi.org/10.18632/oncotarget.23208
Ghosn, L., Chaimani, A., Evrenoglou, T., Davidson, M., Grana, C., Schmucker, C., Bollig, C., Henschke, N., Sguassero, Y., Nejstgaard, C. H., Menon, S., Nguyen, T. V., Ferrand, G., Kapp, P., Riveros, C., Avila, C., Devane, D., Meerpohl, J. J., Rada, G., & Boutron, I. (2021). Interleukin-6 blocking agents for treating COVID-19: A living systematic review. Cochrane Database of Systematic Reviews, 3, CD013881. https://doi.org/10.1002/14651858.CD013881
Gonzalez-Jaramillo, V., Portilla-Fernandez, E., Glisic, M., Voortman, T., Ghanbari, M., Bramer, W., Chowdhury, R., Nijsten, T., Dehghan, A., Franco, O. H., & Nano, J. (2019). Epigenetics and inflammatory markers: A systematic review of the current evidence. International Journal of Inflammation, 2019, 6273680. https://doi.org/10.1155/2019/6273680
Hickman, D. L., Johnson, J., Vemulapalli, T. H., Crisler, J. R., & Shepherd, R. (2017). Commonly used animal models. In Principles of Animal Research for Graduate and Undergraduate Students (pp. 117-175). Elsevier. https://doi.org/10.1016/B978-0-12-802151-4.00007-4
Islam, Z., Islam, S. M. R., Hossen, F., Mahtab-Ul-Islam, K., Hasan, M. R., & Karim, R. (2021). Moringa oleifera is a prominent source of nutrients with potential health benefits. International Journal of Food Science, 2021, 6627265. https://doi.org/10.1155/2021/6627265
Kou, X., Li, B., Olayanju, J. B., Drake, J. M., & Chen, N. (2018). Nutraceutical or pharmacological potential of Moringa oleifera Lam. Nutrients, 10(3), 343. https://doi.org/10.3390/nu10030343
Leone, A., Spada, A., Battezzati, A., Schiraldi, A., Aristil, J., & Bertoli, S. (2015). Cultivation, genetic, ethnopharmacology, phytochemistry and pharmacology of Moringa oleifera leaves: An overview. International Journal of Molecular Sciences, 16(6), 12791-12835. https://doi.org/10.3390/ijms160612791
Luetragoon, T., Sranujit, R. P., Noysang, C., Thongsri, Y., Potup, P., Suphrom, N., Nuengchamnong, N., & Usuwanthim, K. (2020). Bioactive compounds in Moringa oleifera Lam. leaves inhibit the pro-inflammatory mediators in lipopolysaccharide-induced human monocyte-derived macrophages. Molecules, 25(1), 191. https://doi.org/10.3390/molecules25010191
Mahajan, S. G., & Mehta, A. A. (2008). Effect of Moringa oleifera Lam. seed extract on ovalbumin-induced airway inflammation in guinea pigs. Inhalation Toxicology, 20(10), 897-909. https://doi.org/10.1080/08958370802027443
Mahajan, S. G., & Mehta, A. A. (2011). Suppression of ovalbumin-induced Th2-driven airway inflammation by beta-sitosterol in a guinea pig model of asthma. European Journal of Pharmacology, 650(1), 458-464. https://doi.org/10.1016/j.ejphar.2010.09.075
Mahajan, S. G., Banerjee, A., Chauhan, B. F., Padh, H., Nivsarkar, M., & Mehta, A. A. (2009). Inhibitory effect of n-butanol fraction of Moringa oleifera Lam. seeds on ovalbumin-induced airway inflammation in a guinea pig model of asthma. International Journal of Toxicology, 28(6), 519-527. https://doi.org/10.1177/1091581809345165
Mahajan, S. G., Mali, R. G., & Mehta, A. A. (2007a). Effect of Moringa oleifera Lam. seed extract on toluene diisocyanate-induced immune-mediated inflammatory responses in rats. Journal of Immunotoxicology, 4(2), 85-96. https://doi.org/10.1080/15476910701337472
Mahajan, S. G., Mali, R. G., & Mehta, A. A. (2007b). Protective effect of ethanolic extract of seeds of Moringa oleifera Lam. against inflammation associated with development of arthritis in rats. Journal of Immunotoxicology, 4(1), 39-47. https://doi.org/10.1080/15476910601115184
Maskrey, B. H., Megson, I. L., Whitfield, P. D., & Rossi, A. G. (2011). Mechanisms of resolution of inflammation: A focus on cardiovascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 31(5), 1001-1006. https://doi.org/10.1161/ATVBAHA.110.213850
Mihara, M., Ohsugi, Y., & Kishimoto, T. (2011). Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for treatment of rheumatoid arthritis. Open Access Rheumatology: Research and Reviews, 3, 19-29. https://doi.org/10.2147/OARRR.S17118
Mittal, A., Sharma, M., David, A., Vishwakarma, P., Saini, M., Goel, M., & Saxena, K. K. (2017). An experimental study to evaluate the anti-inflammatory effect of Moringa oleifera leaves in animal models. International Journal of Basic & Clinical Pharmacology, 6(2), 452-457. https://doi.org/10.18203/2319-2003.ijbcp20170347
Mthiyane, F. T., Dludla, P. V., & Ziqubu, K. (2022). A review on the antidiabetic properties of Moringa oleifera extracts: Focusing on oxidative stress and inflammation as main therapeutic targets. Frontiers in Pharmacology, 13, 940572. https://doi.org/10.3389/fphar.2022.940572
Ray, S. J., Wolf, T. J., & Mowa, C. N. (2017). Moringa oleifera and inflammation: A mini-review of its effects and mechanisms. Acta Horticulturae, 1158, 317-330. https://doi.org/10.17660/ActaHortic.2017.1158.36
Rincon, M. (2012). Interleukin-6: From an inflammatory marker to a target for inflammatory diseases. Trends in Immunology, 33(11), 571-577. https://doi.org/10.1016/j.it.2012.07.003
Tricco, A. C., Lillie, E., Zarin, W., O’Brien, K. K., Colquhoun, H., Levac, D., Moher, D., Peters, M. D. J., Ma, Q., Horsley, T., Weeks, L., Hempel, S., Akl, E. A., Chang, C., McGowan, J., Stewart, L., Hartling, L., Aldcroft, A., Wilson, M. G., et al. (2018). PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Annals of Internal Medicine, 169(7), 467-473. https://doi.org/10.7326/M18-0850
Unver, N., & McAllister, F. (2018). IL-6 family cytokines: Key inflammatory mediators as biomarkers and potential therapeutic targets. Cytokine & Growth Factor Reviews, 41, 10-17. https://doi.org/10.1016/j.cytogfr.2018.04.004
Wen, Z., Tian, H., Liang, Y., Guo, Y., Deng, M., Liu, G., Li, Y., Liu, D., & Sun, B. (2022). Moringa oleifera polysaccharide regulates colonic microbiota and immune repertoire in C57BL/6 mice. International Journal of Biological Macromolecules, 198, 135-146. https://doi.org/10.1016/j.ijbiomac.2021.12.085
Yong-Bing, X., Gui-Lin, C., & Ming-Quan, G. (2019). Antioxidant and anti-inflammatory activities of the crude extracts of Moringa oleifera from Kenya and their correlations with flavonoids. Antioxidants, 8(8), 296. https://doi.org/10.3390/antiox8080296
Zhang, Y., Peng, L., Li, W., Dai, T., Nie, L., Xie, J., Ai, Y., Li, L., Tian, Y., & Sheng, J. (2020). Polyphenol extract of Moringa oleifera leaves alleviates colonic inflammation in dextran sulfate sodium-treated mice. Evidence-Based Complementary and Alternative Medicine, 2020, 6295402. https://doi.org/10.1155/2020/6295402
Unduhan
Diterbitkan
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2026 Muhammad Husni Fansury Nasution, Sarah Rahmayani Siregar, Maulana Ikhsan, Rivhan Fauzan, Dwi Martha Nur Aditya, Putri Eka Sari, Anis En Nabiilah, Muhammad Khalid Mirza, Andi Saputra

Artikel ini berlisensiCreative Commons Attribution-ShareAlike 4.0 International License.











